Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by MDPI AG, 2023
ISBN 10: 3036594396ISBN 13: 9783036594392
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book Print on Demand
HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by MDPI AG, 2023
ISBN 10: 3036594396ISBN 13: 9783036594392
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Book Print on Demand
HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by LAP Lambert Academic Publishing 2012-11, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: Chiron Media, Wallingford, United Kingdom
Book
PF. Condition: New.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Recent reports have demonstrated that topical ocular administration of naltrexone (an opioid growth factor antagonist) is able to reverse the diabetic complications on the cornea (diabetic keratopathy). The topical administration of naltrexone accelerates corneal wound healing, restores corneal sensitivity and enhances corneal epithelialisation in diabetic rats, rabbits and humans. Naltrexone can be considered as a new therapeutic agent for treatment of diabetic keratopathy. To our best knowledge, an ophthalmic formulation has not yet been developed for naltrexone hydrochloride (NTX) nor has it been properly formulated in a liquid dosage form. This book is designed of six chapters. The first chapter includes a general introduction to the major constraints for topical ocular drug delivery, and a review on new therapeutic approaches in treatment of diabetic keratopathy. The second chapter is preformulation studies of NTX and followed by two formulation chapters for niosomes (non-ionic surfactant vesicles). Chapter five deals with evaluation of niosomes for ocular delivery of NTX and finally chapter six presents a general discussion and direction for future research. 332 pp. Englisch.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book Print on Demand
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Book Print on Demand
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Recent reports have demonstrated that topical ocular administration of naltrexone (an opioid growth factor antagonist) is able to reverse the diabetic complications on the cornea (diabetic keratopathy). The topical administration of naltrexone accelerates corneal wound healing, restores corneal sensitivity and enhances corneal epithelialisation in diabetic rats, rabbits and humans. Naltrexone can be considered as a new therapeutic agent for treatment of diabetic keratopathy. To our best knowledge, an ophthalmic formulation has not yet been developed for naltrexone hydrochloride (NTX) nor has it been properly formulated in a liquid dosage form. This book is designed of six chapters. The first chapter includes a general introduction to the major constraints for topical ocular drug delivery, and a review on new therapeutic approaches in treatment of diabetic keratopathy. The second chapter is preformulation studies of NTX and followed by two formulation chapters for niosomes (non-ionic surfactant vesicles). Chapter five deals with evaluation of niosomes for ocular delivery of NTX and finally chapter six presents a general discussion and direction for future research.
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Abdelkader HamdyDr Hamdy Abdelkader received his BPharm from Alexandria University, Egypt in 2000 and he has been a registered pharmacist since 2001. Hamdy received his PhD in Pharmaceutics from The University of Auckland, New Zealan.
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659294802ISBN 13: 9783659294808
Seller: Mispah books, Redhill, SURRE, United Kingdom
Book
Paperback. Condition: Like New. Like New. book.